Tag: Amsbio

Stem cell culture medium for regenerative medicine

A clinical grade stem cell culture for regenerative medicine, StemFit Basic03, has been launched by Amsbio. Provided ready to use from an animal-origin free, the StemFit Basic03 medium provides stable and reproducible culture condition for induced pluripotent stem and embryonic…

Unblinding the immune system to colon cancer

Researchers in Barcelona report progress in the use of 3D organoid technology to create an analogue of human colon cancer in a mouse model. The study, from the Institute for Research in Biomedicine (IRB), shows that the hormone (transforming growth…

These human cells are similar to embryonic angioblasts

AN EXPANDED catalogue of primary and progenitor cell types and media with a new range of human endothelial progenitor cells (EPC) has been announced by Amsbio. These human EPCs are derived from bone marrow and have properties similar to embryonic…

Progenitor cell line supports Crispr/Cas9 gene editing

A RANGE of progenitor cells derived from healthy mouse small intestine tissue will be of particular interest to research groups using BME 2 organoid matrix and specialising in drug screening applications, says Amsbio. The company has extended its product range…

Extract genomic DNA from plant tissue more efficiently

MAGNETIC bead technology has been applied in various laboratory activities, often bringing advantages in terms of speed and convenience when separating samples into compounds of interest. Amsbio says its new MagSi-DNA Vegetal kit brings the convenience and cost effectiveness of…

Recombinant antigens and antibodies to Zika virus

ZIKA virus is presently causing significant worldwide concern due its rapid spread across the globe and suggested connection to a neurological birth disorder. The outbreak began in Brazil in 2015 and has since spread throughout South and Central America, and…

CRISPR cloning kits for precise genome editing

CRISPR/Cas gene editing is a relatively new technique which offers high accuracy in gene targeting and better target sequence selection, with less complexity and less off-target toxicity than previous genome editing technologies. Amsbio provides a standalone premade Cas9 expression lentivirus,…

Qualified human feeder cells for iPSC reprogramming

A NEW range of human feeder cells from Amsbio are qualified for induced Pluripotent Stem Cell (iPSC) reprogramming.  These newborn human foreskin fibroblasts, available under the trade name NuFF-RQ, are validated to support iPSC colony generation, providing an optimised feeder…